Model of methadone-induced hyperalgesia in rats and effect of memantine

European Journal of Pharmacology

Volumn 626, Issue 2-3, 2010, Pages 229-233

  Hay, Justin L ^a   Kaboutari, Jahangir ^a,b   White, Jason M ^a   Salem, Abdallah ^a   Irvine, Rod ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b SHAHREKORD UNIVERSITY   (Iran)

Author keywords

Hyperalgesia; Memantine; Methadone; Pain

Indexed keywords

MEMANTINE; METHADONE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG DELIVERY SYSTEM; DRUG EFFECT; HYPERALGESIA; IMPLANTATION; LATENT PERIOD; MALE; NOCICEPTION; NONHUMAN; OSMOTIC PUMP; PAIN ASSESSMENT; PAIN THRESHOLD; PRIORITY JOURNAL; RAT;

ANIMALS; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; HYPERALGESIA; MALE; MEMANTINE; METHADONE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 70649088848     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.09.056     Document Type: Article

References (50)

1. Allen R.M., and Dykstra L.A. Attenuation of mu-opioid tolerance and cross-tolerance by the competitive N-methyl-D-aspartate receptor antagonist LY235959 is related to tolerance and cross-tolerance magnitude. J. Pharmacol. Exp. Ther. 295 (2000) 1012-1021
2. Athanasos P., Smith C.S., White J.M., Somogyi A.A., Bochner F., and Ling W. Methadone maintenance patients are cross-tolerant to the antinociceptive effects of very high plasma morphine concentrations. Pain 120 (2006) 267-275
3. Bartok R.E., and Craft R.M. Sex differences in opioid antinociception. J. Pharmacol. Exp. Ther. 282 (1997) 769-778
4. Bell R.F. Low-dose subcutaneous ketamine infusion and morphine tolerance. Pain 83 (1999) 101-103
5. Bläsig J., Herz A., Reinhold K., and Zieglgansberger S. Development of physical dependence on morphine in respect to time and dosage and quantification of the precipitated withdrawal syndrome in rats. Psychopharmacologia 33 (1973) 19-38
6. Bulka A., Wiesenfeld-Hallin Z., and Xu X.J. Differential antinociception by morphine and methadone in two sub-strains of Sprague-Dawley rats and its potentiation by dextromethorphan. Brain Res. 942 (2002) 95-100
7. Célèrier E., Laulin J., Larcher A., Le Moal M., and Simonnet G. Evidence for opiate-activated NMDA processes masking opiate analgesia in rats. Brain Res. 847 (1999) 18-25
8. Célèrier E., Laulin J.P., Corcuff J.B., Le Moal M., and Simonnet G. Progressive enhancement of delayed hyperalgesia induced by repeated heroin administration: a sensitization process. J. Neurosci. 21 (2001) 4074-4080
9. Chang G., Chen L., and Mao J. Opioid tolerance and hyperalgesia. Med. Clin. North Am. 91 (2007) 199-211
10. Codd E.E., Shank R.P., Schupsky J.J., and Raffa R.B. Serotonin and norepinephrine uptake inhibiting activity of centrally acting analgesics: structural determinants and role in antinociception. J. Pharmacol. Exp. Ther. 274 (1995) 1263-1270
11. Compton P.A., Ling W., and Torrington M.A. Lack of effect of chronic dextromethorphan on experimental pain tolerance in methadone-maintained patients. Addict. Biol. 13 (2008) 393-402
12. Crain S.M., and Shen K. Enhanced analgesic potency and reduced tolerance of morphine in 129/SvEv mice: evidence for a deficiency in GM1 ganglioside-regulated excitatory opioid receptor functions. Brain Res. 856 (2000) 227-235
13. Crain S.M., and Shen K.F. After GM1 ganglioside treatment of sensory neurons naloxone paradoxically prolongs the action potential but still antagonizes opioid inhibition. J. Pharmacol. Exp. Ther. 260 (1992) 182-186
14. Crain S.M., and Shen K.F. Modulation of opioid analgesia, tolerance and dependence by Gs-coupled, GM1 ganglioside-regulated opioid receptor functions. Trends Pharmacol. Sci. 19 (1998) 358-365
15. Crain S.M., and Shen K.F. Acute thermal hyperalgesia elicited by low-dose morphine in normal mice is blocked by ultra-low-dose naltrexone, unmasking potent opioid analgesia. Brain Res. 888 (2001) 75-82
16. Davies M.F., Haimor F., Lighthall G., and Clark J.D. Dexmedetomidine fails to cause hyperalgesia after cessation of chronic administration. Anesth. Analg. 96 (2003) 195-200
17. Davis A.M., and Inturrisi C.E. d-Methadone blocks morphine tolerance and N-methyl-D-aspartate-induced hyperalgesia. J. Pharmacol. Exp. Ther. 289 (1999) 1048-1053
18. Doverty M., White J.M., Somogyi A.A., Bochner F., Ali R., and Ling W. Hyperalgesic responses in methadone maintenance patients. Pain 90 (2001) 91-96
19. Ebert B., Andersen S., and Krogsgaard-Larsen P. Ketobemidone, methadone and pethidine are non-competitive N-methyl-D-aspartate (NMDA) antagonists in the rat cortex and spinal cord. Neurosci. Lett. 187 (1995) 165-168
20. Gardell L.R., King T., Ossipov M.H., Rice K.C., Lai J., Vanderah T.W., and Porreca F. Opioid receptor-mediated hyperalgesia and antinociceptive tolerance induced by sustained opiate delivery. Neurosci. Lett. 396 (2006) 44-49
21. Gardell L.R., Wang R., Burgess S.E., Ossipov M.H., Vanderah T.W., Malan Jr. T.P., Lai J., and Porreca F. Sustained morphine exposure induces a spinal dynorphin-dependent enhancement of excitatory transmitter release from primary afferent fibers. J. Neurosci. 22 (2002) 6747-6755
22. Gorman A.L., Elliott K.J., and Inturrisi C.E. The d- and l-isomers of methadone bind to the non-competitive site on the N-methyl-D-aspartate (NMDA) receptor in rat forebrain and spinal cord. Neurosci. Lett. 223 (1997) 5-8
23. Hargreaves K., Dubner R., Brown F., Flores C., and Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32 (1988) 77-88
24. Hay J.L., White J.M., Bochner F., Somogyi A.A., Semple T.J., and Rounsefell B. Hyperalgesia in opioid-managed chronic pain and opioid-dependent patients. J. Pain 10 (2009) 316-322
25. Hesselink M.B., Smolders H., De Boer A.G., Breimer D.D., and Danysz W. Modifications of the behavioral profile of non-competitive NMDA receptor antagonists, memantine, amantadine and (+)MK-801 after chronic administration. Behav. Pharmacol. 10 (1999) 85-98
26. Holtman Jr. J.R., and Wala E.P. Characterization of the antinociceptive effect of oxycodone in male and female rats. Pharmacol. Biochem. Behav. 83 (2006) 100-108
27. Holtman Jr. J.R., and Wala E.P. Characterization of the antinociceptive and pronociceptive effects of methadone in rats. Anesthesiology 106 (2007) 563-571
28. Ingoglia N.A., and Dole V.P. Localization of d- and l-methadone after intraventricular injection into rat brains. J. Pharmacol. Exp. Ther. 175 (1970) 84-87
29. Kristensen K., Christensen C.B., and Christrup L.L. The mu1, mu2, delta, kappa opioid receptor binding profiles of methadone stereoisomers and morphine. Life Sci. 56 (1995) 45-50
30. Laulin J.P., Célèrier E., Larcher A., Le Moal M., and Simonnet G. Opiate tolerance to daily heroin administration: an apparent phenomenon associated with enhanced pain sensitivity. Neuroscience 89 (1999) 631-636
31. Laulin J.P., Maurette P., Corcuff J.B., Rivat C., Chauvin M., and Simonnet G. The role of ketamine in preventing fentanyl-induced hyperalgesia and subsequent acute morphine tolerance. Anesth. Analg. 94 (2002) 1263-1269 table of contents
32. Li X., Angst M.S., and Clark J.D. A murine model of opioid-induced hyperalgesia. Brain Res. Mol. Brain Res. 86 (2001) 56-62
33. Li X., Angst M.S., and Clark J.D. Opioid-induced hyperalgesia and incisional pain. Anesth. Analg. 93 (2001) 204-209
34. Mao J., Price D.D., Lu J., and Mayer D.J. Antinociceptive tolerance to the mu-opioid agonist DAMGO is dose-dependently reduced by MK-801 in rats. Neurosci. Lett. 250 (1998) 193-196
35. Mao J., Price D.D., and Mayer D.J. Thermal hyperalgesia in association with the development of morphine tolerance in rats: roles of excitatory amino acid receptors and protein kinase C. J. Neurosci. 14 (1994) 2301-2312
36. Mao J., Price D.D., and Mayer D.J. Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions. Pain 62 (1995) 259-274
37. Misztal M., Frankiewicz T., Parsons C.G., and Danysz W. Learning deficits induced by chronic intraventricular infusion of quinolinic acid-protection by MK-801 and memantine. Eur. J. Pharmacol. 296 (1996) 1-8
38. NHMRC. Australian Code of practice for the care and use of animals for scientific purposes (2004), Commonwealth of Australia, Canberra
39. Peckham E.M., and Traynor J.R. Comparison of the antinociceptive response to morphine and morphine-like compounds in male and female Sprague-Dawley rats. J. Pharmacol. Exp. Ther. 316 (2006) 1195-1201
40. Pierce T.L., Hope W., and Raper C. The induction and quantitation of methadone dependence in the rat. J. Pharmacol. Toxicol. Methods 36 (1996) 137-146
41. Porreca F., Ossipov M.H., and Gebhart G.F. Chronic pain and medullary descending facilitation. Trends Neurosci. 25 (2002) 319-325
42. Rodriguez M., Carlos M.A., Ortega I., Suarez E., Calvo R., and Lukas J.C. Sex specificity in methadone analgesia in the rat: a population pharmacokinetic and pharmacodynamic approach. Pharm. Res. 19 (2002) 858-867
43. Scott C.C. Pharmacological comparison of the optical isomers of methadone. J. Pharmacol. Exp. Ther. 92 (1948) 282-286
44. South S.M., Wright A.W., Lau M., Mather L.E., and Smith M.T. Sex-related differences in antinociception and tolerance development following chronic intravenous infusion of morphine in the rat: modulatory role of testosterone via morphine clearance. J. Pharmacol. Exp. Ther. 297 (2001) 446-457
45. Trujillo K.A., and Akil H. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science 251 (1991) 85-87
46. Urban M.O., and Gebhart G.F. Supraspinal contributions to hyperalgesia. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 7687-7692
47. Vanderah T.W., Gardell L.R., Burgess S.E., Ibrahim M., Dogrul A., Zhong C.M., Zhang E.T., Malan Jr. T.P., Ossipov M.H., Lai J., and Porreca F. Dynorphin promotes abnormal pain and spinal opioid antinociceptive tolerance. J. Neurosci. 20 (2000) 7074-7079
48. Vanderah T.W., Ossipov M.H., Lai J., Malan Jr. T.P., and Porreca F. Mechanisms of opioid-induced pain and antinociceptive tolerance: descending facilitation and spinal dynorphin. Pain 92 (2001) 5-9
49. Vanderah T.W., Suenaga N.M., Ossipov M.H., Malan Jr. T.P., Lai J., and Porreca F. Tonic descending facilitation from the rostral ventromedial medulla mediates opioid-induced abnormal pain and antinociceptive tolerance. J. Neurosci. 21 (2001) 279-286
50. Yamada K., Takayanagi M., Kamei H., Nagai T., Dohniwa M., Kobayashi K., Yoshida S., Ohhara T., Takuma K., and Nabeshima T. Effects of memantine and donepezil on amyloid beta-induced memory impairment in a delayed-matching to position task in rats. Behav. Brain Res. 162 (2005) 191-199